First Tracks Biotherapeutics (TRAX) Stock Price
First Tracks Biotherapeutics Price
The consensus 12-month price target for First Tracks Biotherapeutics is 60.00 USD, about 88.7% above where the stock trades today. Of 15 analysts, 14 rate the stock a buy — an overall Buy consensus.
First Tracks Biotherapeutics stock price
First Tracks Biotherapeutics business model & stock analysis
Frequently asked questions about First Tracks Biotherapeutics
Analysts currently set an average price target of 63.29 USD for the First Tracks Biotherapeutics stock (median: 60.00 USD), implying +99.0 % versus the latest price. The consensus is based on 15 analyst ratings.
15 analysts currently rate the First Tracks Biotherapeutics stock: 14 recommend buying, 1 holding and 0 selling. For 2026, analysts expect First Tracks Biotherapeutics to generate revenue of 75.00 M USD and earnings per share of -4.14 USD.
Converted at the current exchange rate, the First Tracks Biotherapeutics share trades at 28.38 EUR (31.80 USD).
The expected revenue of First Tracks Biotherapeutics is 75.00 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of First Tracks Biotherapeutics is -143.84 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of First Tracks Biotherapeutics is currently -7.68. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the First Tracks Biotherapeutics stock.
The price-to-sales ratio (P/S) of First Tracks Biotherapeutics is currently 14.73. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the First Tracks Biotherapeutics stock.
The Eulerpool Quality Score for First Tracks Biotherapeutics is 2/10.
The ISIN of First Tracks Biotherapeutics is US3371851029. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of First Tracks Biotherapeutics is TRAX. The ticker symbol is used to trade First Tracks Biotherapeutics shares on the stock exchange.
First Tracks Biotherapeutics stock
First Tracks Biotherapeutics Peer Group
All fundamentals and in-depth analysis of First Tracks Biotherapeutics
Our stock analysis for First Tracks Biotherapeutics stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of First Tracks Biotherapeutics. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.